Veracyte, Inc.

VCYTNASDAQHealthcare● Active

$47.27

$-1.46(-3.00%)

Market Cap$3.8B

P/E Ratio—

52W High$50.71

52W Low$22.61

Avg Volume1.0M

Open$48.87

Beta1.98

Insider Trades Ownership Employees

Veracyte, Inc. (VCYT) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · VCYT · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Veracyte, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

VCYT insider buying and selling by quarter

VCYT insider selling · VCYT insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

658K329K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · VCYT ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

VCYT executive sell shares · VCYT board member insider trading · VCYT insider trading SEC filing

Showing 92 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jun 2, 2026	McGuire Annie EVP, General Counsel	Other	3,292	$47.80	$157K	140,416	Form 4
Jun 4, 2026	McGuire Annie EVP, General Counsel	Sale	1,400	$49.31	$69K	139,016	Form 4
Jun 4, 2026	McGuire Annie EVP, General Counsel	Sale	1,776	$50.12	$89K	137,240	Form 4
Jun 2, 2026	Wygant Jonathan VP, Chief Accounting Officer	Other	1,361	$47.80	$65K	44,073	Form 4
Jun 2, 2026	Chambers Rebecca CFO	Other	3,693	$47.80	$177K	176,841	Form 4
Jun 4, 2026	Chambers Rebecca CFO	Sale	1,600	$49.28	$79K	175,241	Form 4
Jun 4, 2026	Chambers Rebecca CFO	Sale	1,961	$50.09	$98K	173,280	Form 4
Jun 2, 2026	Febbo Phillip G. Chief Scientific & Med Officer	Other	3,730	$47.80	$178K	149,797	Form 4
Jun 4, 2026	Stapley Marc CEO · Director	Option	138,051	$36.60	$5.05M⚡	578,545	Form 4
Jun 2, 2026	Stapley Marc CEO · Director	Other	9,012	$47.80	$431K	440,494	Form 4
Jun 4, 2026	Stapley Marc CEO · Director	Sale	138,051	$50.12	$6.92M⚡	440,494	Form 4
Jun 2, 2026	Leite John Global Chief Commercial Off	Other	4,059	$47.80	$194K	146,280	Form 4
Jun 4, 2026	Leite John Global Chief Commercial Off	Sale	13,975	$50.07	$700K	132,305	Form 4
May 22, 2026	Wygant Jonathan VP, Chief Accounting Officer	Option	24,000	$24.80	$595K	69,434	Form 4
May 22, 2026	Wygant Jonathan VP, Chief Accounting Officer	Sale	24,000	$45.40	$1.09M⚡	45,434	Form 4
May 20, 2026	EPSTEIN ROBERT S Director	Sale	10,000	$44.01	$440K	52,446	Form 4
May 6, 2026	McGuire Annie SVP, General Counsel	Sale	5,102	$38.05	$194K	148,810	Form 4
May 6, 2026	McGuire Annie SVP, General Counsel	Sale	5,102	$40.00	$204K	143,708	Form 4
Apr 10, 2026	Haas Kevin Richard Chief Dev and Tech Officer	Award	44,221	—	—	44,221	Form 4
Mar 6, 2026	Wygant Jonathan VP, Chief Accounting Officer	Award	10,525	—	—	45,434	Form 4
Mar 6, 2026	McGuire Annie SVP, General Counsel	Award	26,314	—	—	153,912	Form 4
Mar 6, 2026	McGuire Annie SVP, General Counsel	Award	32,892	—	—	127,598	Form 4
Mar 6, 2026	Febbo Phillip G. Chief Scientific & Med Officer	Award	6,578	—	—	153,527	Form 4
Mar 6, 2026	Febbo Phillip G. Chief Scientific & Med Officer	Award	29,603	—	—	146,949	Form 4
Mar 6, 2026	Leite John Chief Commercial Officer-CLIA	Award	6,578	—	—	150,339	Form 4

McGuire Annie

EVP, General Counsel

Other

Date

Jun 2

3,292

Price

$47.80

Value

$157K

View Form 4 on SEC.gov

McGuire Annie

EVP, General Counsel

Sale

Date

Jun 4

1,400

Price

$49.31

Value

$69K

View Form 4 on SEC.gov

McGuire Annie

EVP, General Counsel

Sale

Date

Jun 4

1,776

Price

$50.12

Value

$89K

View Form 4 on SEC.gov

Wygant Jonathan

VP, Chief Accounting Officer

Other

Date

Jun 2

1,361

Price

$47.80

Value

$65K

View Form 4 on SEC.gov

Chambers Rebecca

CFO

Other

Date

Jun 2

3,693

Price

$47.80

Value

$177K

View Form 4 on SEC.gov

Chambers Rebecca

CFO

Sale

Date

Jun 4

1,600

Price

$49.28

Value

$79K

View Form 4 on SEC.gov

Chambers Rebecca

CFO

Sale

Date

Jun 4

1,961

Price

$50.09

Value

$98K

View Form 4 on SEC.gov

Febbo Phillip G.

Chief Scientific & Med Officer

Other

Date

Jun 2

3,730

Price

$47.80

Value

$178K

View Form 4 on SEC.gov

Stapley Marc

CEO · Director

Option

Date

Jun 4

138,051

Price

$36.60

Value

$5.05M ⚡

View Form 4 on SEC.gov

Stapley Marc

CEO · Director

Other

Date

Jun 2

9,012

Price

$47.80

Value

$431K

View Form 4 on SEC.gov

Stapley Marc

CEO · Director

Sale

Date

Jun 4

138,051

Price

$50.12

Value

$6.92M ⚡

View Form 4 on SEC.gov

Leite John

Global Chief Commercial Off

Other

Date

Jun 2

4,059

Price

$47.80

Value

$194K

View Form 4 on SEC.gov

Leite John

Global Chief Commercial Off

Sale

Date

Jun 4

13,975

Price

$50.07

Value

$700K

View Form 4 on SEC.gov

Wygant Jonathan

VP, Chief Accounting Officer

Option

Date

May 22

24,000

Price

$24.80

Value

$595K

View Form 4 on SEC.gov

Wygant Jonathan

VP, Chief Accounting Officer

Sale

Date

May 22

24,000

Price

$45.40

Value

$1.09M ⚡

View Form 4 on SEC.gov

EPSTEIN ROBERT S

Director

Sale

Date

May 20

10,000

Price

$44.01

Value

$440K

View Form 4 on SEC.gov

McGuire Annie

SVP, General Counsel

Sale

Date

May 6

5,102

Price

$38.05

Value

$194K

View Form 4 on SEC.gov

McGuire Annie

SVP, General Counsel

Sale

Date

May 6

5,102

Price

$40.00

Value

$204K

View Form 4 on SEC.gov

Haas Kevin Richard

Chief Dev and Tech Officer

Award

Date

Apr 10

44,221

Price

—

Value

—

View Form 4 on SEC.gov

Wygant Jonathan

VP, Chief Accounting Officer

Award

Date

Mar 6

10,525

Price

—

Value

—

View Form 4 on SEC.gov

McGuire Annie

SVP, General Counsel

Award

Date

Mar 6

26,314

Price

—

Value

—

View Form 4 on SEC.gov

McGuire Annie

SVP, General Counsel

Award

Date

Mar 6

32,892

Price

—

Value

—

View Form 4 on SEC.gov

Febbo Phillip G.

Chief Scientific & Med Officer

Award

Date

Mar 6

6,578

Price

—

Value

—

View Form 4 on SEC.gov

Febbo Phillip G.

Chief Scientific & Med Officer

Award

Date

Mar 6

29,603

Price

—

Value

—

View Form 4 on SEC.gov

Leite John

Chief Commercial Officer-CLIA

Award

Date

Mar 6

6,578

Price

—

Value

—

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About VCYT insider trading

VCYT insider trades

Veracyte, Inc. (VCYT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including McGuire Annie (EVP, General Counsel), Chambers Rebecca (CFO), Stapley Marc (CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. VCYT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Veracyte, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

VCYT insider trading · 5 questions

The insiders of Veracyte, Inc. (VCYT) include executives and directors such as McGuire Annie (EVP, General Counsel), Chambers Rebecca (CFO), Stapley Marc (CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

VCYT board member insider tradingwho are VCYT insidersVCYT insider rosterVeracyte, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026